Phase 2 Second Line Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
Ramucirumab (Cyramza), Nal-IRI (ONIVYDE) and Trifluridine/Tipiracil (Lonsurf) in Second Line Metastatic Gastric Cancer .
ChemotherapyMetastatic Gastric AdenocarcinomaSecond Line
National Health Research Institutes, Taiwan45 enrolled1 locationNCT05927857
Terminated
Phase 2
NIVORAD - A randomised phase 2 trial of nivolumab and stereotactic ablative body radiotherapy in advanced non-small cell lung cancer, progressing after first or second line chemotherapy.
Advanced non-small cell lung cancer, progressing after first of second line chemotherapy
University of Sydney120 enrolled25 locationsACTRN12616000352404
Completed
Phase 2
ATTAX 2
Advanced oesophago-gastric cancer post docetaxel failure (second line treatment)
Australian Gastro-Intestinal Trials Group35 enrolled1 locationACTRN12606000181505